Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $62.90 | Total: $314.50 |
| 1 | 10 | $53.28 | Total: $532.80 |
| 1 | 25 | $45.14 | Total: $1,128.50 |
| 1 | 50 | $38.48 | Total: $1,924.00 |
| 1 | 100 | $33.30 | Total: $3,330.00 |
Overview
Mitoquidone, a novel pentacyclic pyrroloquinone, is a potential anticancer agent. Mitoquidone showed good activity in a range of experimental solid tumour models and did not exhibit significant cytotoxicity.
Chemical Properties
| Molecular Formula | C20H13NO2 |
| Molecular Weight | 299.32 |
| CAS Numbers | 91753-07-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1C2=C3N(C=C2C(=O)C=4C1=CC=CC4)CC=5C(C3)=CC=CC5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Speth PA, et al. Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol. 1988 ; 21[4] 343-346.